Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Hedge Fund Glenview Used ‘Medicare-for-All’ Rout to Build Up Health Stakes

Published 05/16/2019, 08:21 AM
Updated 05/16/2019, 12:40 PM
© Bloomberg. A monitor displays Cigna Corp. signage on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Monday, March 19, 2018. Stocks declined globally on Monday amid a technology selloff and as investors braced for a week packed with risk events, from central bank decisions to a G-20 gathering. Government bonds also fell, while the pound jumped on a Brexit breakthrough. Photographer: Michael Nagle/Bloomberg

(Bloomberg) -- U.S. health-care investor Glenview Capital Management LLC boosted its positions in health insurers and hospitals as the sectors came under pressure from political headlines in the first few months of the year.

Glenview Capital added to its holdings of Cigna Corp (NYSE:CI), Anthem (NYSE:ANTM) Inc. and Humana Inc (NYSE:HUM)., while taking new stakes in Centene (NYSE:CNC) Corp. and Wellcare Health Plans Inc., which announced plans to merge at the end of March. Among hospitals, the New York-based hedge fund bought more shares of Tenet Healthcare Corp (NYSE:THC). and Universal Health Services Inc (NYSE:UHS)., its latest 13-F filings show. Glenview remains Tenet’s largest shareholder.

Managed care and hospital shares have been roiled by Washington policy debates centered on offering “Medicare-for-All”. Stocks began to slide in late February and fell to their lowest level since late 2017 at one point in April. While they’ve recovered over the past month, the S&P 500 Managed Care Index remains down for the year, while a Bloomberg Intelligence hospitals benchmark is up 2.6%, significantly underperforming the broader market.

In a Bloomberg interview last week, Glenview founder Larry Robbins said investors were wrong to be fearful of Democrats’ single-payer proposals as they have little chance of becoming reality. He also repeated his bullish call on managed care and hospitals while cautioning against pharmaceutical stocks that may come under pressure due to drug pricing risks.

The hedge fund managed about $7.7 billion as of March 1, down from $10 billion in June of last year.

© Bloomberg. A monitor displays Cigna Corp. signage on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Monday, March 19, 2018. Stocks declined globally on Monday amid a technology selloff and as investors braced for a week packed with risk events, from central bank decisions to a G-20 gathering. Government bonds also fell, while the pound jumped on a Brexit breakthrough. Photographer: Michael Nagle/Bloomberg

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.